DRG 269 Overview

DRG 269 covers inpatient admissions for aortic and mechanical heart assist device procedures, excluding intra-aortic balloon pump placement, when no Major Complication or Comorbidity is present. This Diagnosis-Related Group captures cases with significant resource use related to implantation, exchange, or removal of ventricular assist devices and other durable mechanical circulatory support. It matters for Medicare payment because it groups clinically similar procedures to determine bundled inpatient reimbursement under prospective payment policies. Accurate clinical documentation and coding affect assignment to this Diagnosis-Related Group and therefore the inpatient payment level.

• Acute perioperative device optimization studies: randomized or prospective cohort trials that evaluate timing, hemodynamic support settings, and weaning strategies for patients receiving aortic or nonpulsatile ventricular assist devices in the immediate perioperative period after cardiac surgery. These studies enroll adult patients who require temporary or durable mechanical circulatory support for cardiogenic shock, severe heart failure decompensation, or post-cardiotomy failure, and measure short-term endpoints such as hemodynamic stabilization, organ support needs, and in-hospital mortality. Findings are directly relevant to clinicians managing high-acuity cases in this DRG and to payers because optimized protocols can reduce ICU length of stay, complications, and resource utilization.
• Comparative effectiveness and safety trials of support strategies: observational registry analyses or pragmatic randomized trials comparing types of mechanical support (e.g., different implantable assist devices or peripheral vs central cannulation approaches) and adjunctive management bundles in patients undergoing aortic or heart assist procedures without major complications. These studies focus on heterogeneous adult cardiac surgical populations stratified by indication (acute vs chronic heart failure), comorbidity burden, and risk scores, assessing outcomes such as device-related complications, need for reintervention, transfusion rates, and 30- and 90-day readmissions. Results inform provider choices about device selection and perioperative pathways and help payers and hospitals understand relative value, complication profiles, and likely downstream costs associated with different management options.
• Post-discharge functional and economic outcomes research: prospective cohort studies and health-services research examining quality of life, functional recovery, rehabilitation needs, and healthcare utilization after discharge among survivors of aortic and heart assist procedures who did not have major complications intraoperatively. These studies follow patients for months to a year to quantify readmission rates, outpatient device management needs, durable support transition to transplantation, and cost-effectiveness of follow-up care models. Such evidence guides discharge planning, case management, and reimbursement policy by highlighting which post-acute care strategies improve long-term outcomes and reduce avoidable readmissions and expenditures for this DRG.